黃 溫雅

Medicine & Life Sciences

1. Anaplastic Large-Cell Lymphoma 10%
2. Biomarkers 12%
3. Carcinogenesis 17%
4. Carrier Proteins 8%
5. Chronic Hepatitis B 36%
6. Cyclin A 12%
7. Cyclin-Dependent Kinases 10%
8. DNA 14%
9. DNA Damage 12%
10. DNA Repair 43%
11. Double-Stranded DNA Breaks 9%
12. Endoplasmic Reticulum 13%
13. Endoplasmic Reticulum Stress 38%
14. erythrogenic toxin 13%
15. Genes 21%
16. Genomic Instability 17%
17. Glass 27%
18. Hepatitis B Surface Antigens 18%
19. Hepatitis B virus 100%
20. hepatitis B virus L protein 27%
21. Hepatocellular Carcinoma 59%
22. Liver 14%
23. Membrane Proteins 15%
24. Mutation 9%
25. Neoplasms 9%
26. Nitric Oxide Synthase Type II 9%
27. Oligonucleotide Array Sequence Analysis 15%
28. Oncogene Proteins 10%
29. Peptide Nucleic Acids 8%
30. Polychlorinated Biphenyls 9%
31. Proteasome Endopeptidase Complex 8%
32. Proteins 14%
33. RNA Polymerase II 9%
34. Simplexvirus 8%
35. Surface Antigens 40%
36. T-Cell Lymphoma 15%
37. T-Cell Receptor Genes 11%
38. T-Lymphocyte Gene Rearrangement 9%
39. TOR Serine-Threonine Kinases 9%
40. Transcription Factor TFIIH 12%
41. Xeroderma Pigmentosum 10%
42. Yeasts 19%